Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease

BMC Medical Genomics

Table 1 Summary of the percentage of cells stained for CD3, CD4, CD8, CD20, and CD163 cell markers within the Gorham-Stout disease sample

Sample	Positive (%)	Rho	P value
CD3	8.22	0.997	< 0.0001
CD4	0.06	0.986	< 0.0001
CD8	5.93	0.991	< 0.0001
CD20	4.86	0.995	< 0.0001
CD163	20.01	0.996	< 0.0001

The biopsy sections were stained with the following cell markers: CD3, CD4, CD8, CD20, and CD163. Positively stained cells (expressed as a percentage of total cells) were automatically counted using QuPath (version 0.2.0-m7). The methodology was verified by comparing manual counting with QuPath counting in 0.2 mm. [44,45,46] areas selected randomly across the different sections. Pearson’s correlation (Rho) and P values were calculated

ISSN: 1755-8794